Investor profile
Kadmos Capital has backed 12 European tech companies across 15 funding rounds between 2022 and 2026, joining rounds totalling €92M. Most active in Healthtech and Software. Data as of 7 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Moments Lab | France | 1 | €21M |
| Antiverse | UK | 3 | €15M |
| Jua | Switzerland | 1 | €15M |
| Pathway | France | 1 | €9.5M |
| Aeon | Switzerland |
| 1 |
| €8.2M |
| OutSee | UK | 2 | €5.0M |
| Arda Biomaterials | UK | 1 | €4.6M |
| Scindo | UK | 1 | €4.5M |
| GlycanAge | UK | 1 | €3.9M |
| Xonai | UK | 1 | €3.3M |
| LiveDrop | Netherlands | 1 | €2.2M |
| CheMastery | UK | 1 | €0 |
| €8.2M |
| 2025-06 |
| Antiverse | Series A | €8.0M | 2026-03 |
| Arda Biomaterials | Other | €4.6M | 2025-04 |
| Scindo | Other | €4.5M | 2025-09 |
| Antiverse | Seed | €4.2M | 2024-10 |
| GlycanAge | Seed | €3.9M | 2024-02 |
| Xonai | Seed | €3.3M | 2023-06 |
